T2D Remission Buffers; Another Sotagliflozin Trial; More Gender-Affirming Care Bans?

(MedPage Today) -- People with any evidence of type 2 diabetes remission with diet and lifestyle changes had a 40% lower rate of cardiovascular disease and a 33% lower rate of chronic kidney disease versus those without remission, according to...
Source: MedPage Today Endocrinology - Category: Endocrinology Source Type: news